292 related articles for article (PubMed ID: 31468524)
1. Preparation and preliminary pharmacokinetics study of GNA-loaded zein nanoparticles.
Cheng W; Wang B; Zhang C; Dong Q; Qian J; Zha L; Chen W; Hong L
J Pharm Pharmacol; 2019 Nov; 71(11):1626-1634. PubMed ID: 31468524
[TBL] [Abstract][Full Text] [Related]
2. In vitro/in vivo evaluation of pH-sensitive Gambogenic acid loaded Zein nanoparticles with polydopamine coating.
Zha L; Qian J; Wang B; Liu H; Zhang C; Dong Q; Chen W; Hong L
Int J Pharm; 2020 Sep; 587():119665. PubMed ID: 32702449
[TBL] [Abstract][Full Text] [Related]
3. Nanosuspensions as delivery system for gambogenic acid: characterization and in vitro/in vivo evaluation.
Yuan H; Li X; Zhang C; Pan W; Liang Y; Chen Y; Chen W; Liu L; Wang X
Drug Deliv; 2016 Oct; 23(8):2772-2779. PubMed ID: 26292058
[TBL] [Abstract][Full Text] [Related]
4. Preparation, characterization and preliminary pharmacokinetic study of pH-sensitive Hydroxyapatite/Zein nano-drug delivery system for doxorubicin hydrochloride.
Zha L; Wang B; Qian J; Fletcher B; Zhang C; Dong Q; Chen W; Hong L
J Pharm Pharmacol; 2020 Apr; 72(4):496-506. PubMed ID: 31975457
[TBL] [Abstract][Full Text] [Related]
5. Oral Delivery of Gambogenic Acid by Functional Polydopamine Nanoparticles for Targeted Tumor Therapy.
Wang B; Yuan T; Zha L; Liu Y; Chen W; Zhang C; Bao Y; Dong Q
Mol Pharm; 2021 Mar; 18(3):1470-1479. PubMed ID: 33586444
[TBL] [Abstract][Full Text] [Related]
6. Self-assembled micelles based on gambogenic acid-phospholipid complex for sustained-release drug delivery.
Wang B; Cheng W; Zhang C; Bao Y; Zha L; Qian J; Hong L; Chen W
J Microencapsul; 2019 Sep; 36(6):566-575. PubMed ID: 31411510
[No Abstract] [Full Text] [Related]
7. PEGylated liposomes as delivery systems for Gambogenic acid: Characterization and in vitro/in vivo evaluation.
Tang X; Sun J; Ge T; Zhang K; Gui Q; Zhang S; Chen W
Colloids Surf B Biointerfaces; 2018 Dec; 172():26-36. PubMed ID: 30125771
[TBL] [Abstract][Full Text] [Related]
8. Long circulation nanostructured lipid carriers for gambogenic acid: formulation design, characterization, and pharmacokinetic.
Lin T; Huang X; Wang Y; Zhu T; Luo Q; Wang X; Zhou K; Cheng H; Peng D; Chen W
Xenobiotica; 2017 Sep; 47(9):793-799. PubMed ID: 27618478
[TBL] [Abstract][Full Text] [Related]
9. Nanoparticle Encapsulation Strategy: Leveraging Plant Exine Capsules Used as Secondary Capping for Oral Delivery.
Wu D; Wang X; Wang S; Li B; Liang H
J Agric Food Chem; 2019 Jul; 67(29):8168-8176. PubMed ID: 31268318
[TBL] [Abstract][Full Text] [Related]
10. A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake.
Luo Q; Lin T; Zhang CY; Zhu T; Wang L; Ji Z; Jia B; Ge T; Peng D; Chen W
Int J Pharm; 2015 Sep; 493(1-2):30-9. PubMed ID: 26209071
[TBL] [Abstract][Full Text] [Related]
11. Baicalin-loaded PEGylated lipid nanoparticles: characterization, pharmacokinetics, and protective effects on acute myocardial ischemia in rats.
Zhang S; Wang J; Pan J
Drug Deliv; 2016 Nov; 23(9):3696-3703. PubMed ID: 27749105
[TBL] [Abstract][Full Text] [Related]
12. PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.
Lin T; Fang Q; Peng D; Huang X; Zhu T; Luo Q; Zhou K; Chen W
Drug Deliv; 2013; 20(7):277-84. PubMed ID: 24044645
[TBL] [Abstract][Full Text] [Related]
13. Zein-alpha lipoic acid-loaded nanoparticles to enhance the oral bioavailability of dapoxetine: optimization and clinical pharmacokinetic evaluation.
El-Say KM; Ahmed OA; Mohamed AI; Safo MK; Omar AM
Int J Nanomedicine; 2019; 14():7461-7473. PubMed ID: 31686817
[TBL] [Abstract][Full Text] [Related]
14. Beta carotene-loaded zein nanoparticles to improve the biopharmaceutical attributes and to abolish the toxicity of methotrexate: a preclinical study for breast cancer.
Jain A; Sharma G; Kushwah V; Ghoshal G; Jain A; Singh B; Shivhare US; Jain S; Katare OP
Artif Cells Nanomed Biotechnol; 2018; 46(sup1):402-412. PubMed ID: 29361842
[TBL] [Abstract][Full Text] [Related]
15. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization.
Shahnaz G; Vetter A; Barthelmes J; Rahmat D; Laffleur F; Iqbal J; Perera G; Schlocker W; Dünnhaput S; Augustijns P; Bernkop-Schnürch A
Int J Pharm; 2012 May; 428(1-2):164-70. PubMed ID: 22421322
[TBL] [Abstract][Full Text] [Related]
16. Fabrication of curcumin-zein-ethyl cellulose composite nanoparticles using antisolvent co-precipitation method.
Hasankhan S; Tabibiazar M; Hosseini SM; Ehsani A; Ghorbani M
Int J Biol Macromol; 2020 Nov; 163():1538-1545. PubMed ID: 32784024
[TBL] [Abstract][Full Text] [Related]
17. Preparation, characterization and pharmacokinetic evaluation of rosuvastatin calcium incorporated cyclodextrin-polyanhydride nanoparticles.
Al-Heibshy FNS; Başaran E; Arslan R; Öztürk N; Vural İ; Demirel M
Drug Dev Ind Pharm; 2019 Oct; 45(10):1635-1645. PubMed ID: 31342792
[No Abstract] [Full Text] [Related]
18. TPGS emulsified zein nanoparticles enhanced oral bioavailability of daidzin: in vitro characteristics and in vivo performance.
Zou T; Gu L
Mol Pharm; 2013 May; 10(5):2062-70. PubMed ID: 23557122
[TBL] [Abstract][Full Text] [Related]
19. Alginate coated chitosan core shell nanoparticles for oral delivery of enoxaparin: in vitro and in vivo assessment.
Bagre AP; Jain K; Jain NK
Int J Pharm; 2013 Nov; 456(1):31-40. PubMed ID: 23994363
[TBL] [Abstract][Full Text] [Related]
20. Solid lipid nanoparticles as delivery systems for Gambogenic acid.
Huang X; Chen YJ; Peng DY; Li QL; Wang XS; Wang DL; Chen WD
Colloids Surf B Biointerfaces; 2013 Feb; 102():391-7. PubMed ID: 23010123
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
